GHIF Leads €10 Million Series C Financing for Themis Bioscience
Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline Proceeds will support the further development of the company's chikungunya vaccine candidate VIENNA - January 4, 2018 - Themis announced today the close of a Series C financing round totaling EUR 10 million. Global Health Investment Fund (GHIF), a New York-based impact investment firm focused [...]